Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shannon

Showing results (61-70 of 185) with videos related to

Pageof 19
Sort By:
The Journal of Antimicrobial Chemotherapy|October 1, 1982
Temocillin (BRL 17421): in-vitro antibacterial activity and susceptibility to beta-lactamasesI Phillips, A King, K Shannon, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1980
The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitinA King, C Warren, K Shannon, et al.
Lancet (London, England)|February 6, 1988
Amoxycillin/clavulanate resistant Escherichia coliH Williams, A King, K Shannon, et al.
Family Medicine|July 21, 1998
The accuracy of patient encounter logbooks used by family medicine clerkship studentsC T Patricoski, K Shannon, G A Doyle
The Journal of Antimicrobial Chemotherapy|September 17, 1998
Glycopeptide tolerance in Staphylococcus aureusJ May, K Shannon, A King, et al.
FEMS Microbiology Letters|February 1, 1990
Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15K Shannon, H Williams, A King, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1981
SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamasesI Phillips, A King, K Shannon, et al.
American Journal of Diseases of Children (1960)|March 1, 1982
Multiple hepatic hemangiomas: failure of corticosteroid therapy and successful hepatic artery ligationK Shannon, G R Buchanan, T P Votteler
Antimicrobial Agents and Chemotherapy|April 1, 1982
In vitro antibacterial activity of norfloxacin (MK-0366)A King, C Warren, K Shannon, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|March 20, 2002
Evidence based practice: are critical care nurses ready for it?T Bucknall, B Copnell, K Shannon, et al.
Pageof 19

Showing results (61-70 of 185) with videos related to

Sort By:
Pageof 19
The Journal of Antimicrobial Chemotherapy|October 1, 1982
Temocillin (BRL 17421): in-vitro antibacterial activity and susceptibility to beta-lactamasesI Phillips, A King, K Shannon, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1980
The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitinA King, C Warren, K Shannon, et al.
Lancet (London, England)|February 6, 1988
Amoxycillin/clavulanate resistant Escherichia coliH Williams, A King, K Shannon, et al.
Family Medicine|July 21, 1998
The accuracy of patient encounter logbooks used by family medicine clerkship studentsC T Patricoski, K Shannon, G A Doyle
The Journal of Antimicrobial Chemotherapy|September 17, 1998
Glycopeptide tolerance in Staphylococcus aureusJ May, K Shannon, A King, et al.
FEMS Microbiology Letters|February 1, 1990
Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15K Shannon, H Williams, A King, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1981
SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamasesI Phillips, A King, K Shannon, et al.
American Journal of Diseases of Children (1960)|March 1, 1982
Multiple hepatic hemangiomas: failure of corticosteroid therapy and successful hepatic artery ligationK Shannon, G R Buchanan, T P Votteler
Antimicrobial Agents and Chemotherapy|April 1, 1982
In vitro antibacterial activity of norfloxacin (MK-0366)A King, C Warren, K Shannon, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|March 20, 2002
Evidence based practice: are critical care nurses ready for it?T Bucknall, B Copnell, K Shannon, et al.
Pageof 19